HOME >> MEDICINE >> NEWS
10 years before malaria vaccine is ready for widespread use

A seminar on malaria in this week's issue of THE LANCET states that it will be at least a decade before a vaccine for the disease will be ready for widespread use and emphasises the need to expand the use of existing control methods.

Brian Greenwood (London School of Hygiene and Tropical Medicine, UK) and colleagues state that prevention and treatment of malaria could be greatly improved with existing methods if increased financial and labour resources were available. Combination therapies based on drugs derived from the plant Artemisia annua (ACTs) have now been adopted by many endemic countries, although cost is likely to be a problem in ensuring their widespread use. ACTs are highly effective, even in areas where there is a high level of resistance to other antimalarial drugs. (See this week's issue Lancet 365; 1467-73, Lancet 365; 1474-1480) Insecticide-treated bed-nets provide a simple but effective means of preventing malaria, especially with the development of longlasting nets in which insecticide is incorporated into net fibres and is not removed during washing.

However, the authors state that new approaches to prevention and treatment are needed including malaria vaccines. One malaria vaccine, RTS, S/AS02 has provided substantial, short-lived protection in volunteers exposed experimentally to bites by infected mosquitoes and in semi-immune adults in The Gambia exposed to natural infection. (See Lancet 2001; 358: 1927-34) In a subsequent trial in Mozambican children, the RTS, S/AS02 vaccine gave 30% protection against the first clinical episode of malaria and 58% protection against severe malaria. (See Lancet 2004; 364: 1411-20) Other promising candidates are undergoing clinical trials.

Professor Greenwood states: "Malaria vaccine research has progressed rapidly over the past few years, helped by the availability more funds and by improved organisation mediated through organisations such as the Malaria Vaccine Initiative. However,
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
21-Apr-2005


Page: 1 2

Related medicine news :

1. Researchers find deadly prescription drug effects 6 years before FDA
2. SCAIS Hildner Lecture traces progress through 30 years of interventional cardiology
3. Speeding fingertip discovery -- 20 years of protein info in 1 place
4. Brain structure changes years before memory loss begins
5. New guideline for screening mammography for women 40 to 49 years of age
6. Worldwide Parkinsons cases will double in next 25 years
7. New research says winning a Nobel Prize adds nearly two years to your lifespan
8. Canadian study shows bilingualism has protective effect in delaying onset of dementia by four years
9. High levels of blindness in southern Sudan following years of war
10. Researchers make progress against lung disease attacking women in childbearing years
11. PhD researcher develops inexpensive, sustainable production method in just 2 years

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: years before malaria vaccine ready for widespread use

(Date:10/25/2014)... Steven Reinberg HealthDay Reporter ... virus that causes common cold sores -- herpes simplex -- ... Swedish researchers suggest. In fact, being a carrier of ... Alzheimer,s disease, the researchers found. "The identification of ... disorder is a breakthrough," said lead researcher Dr. Hugo Lovheim, ...
(Date:10/25/2014)... (HealthDay News) -- Researchers who discovered antibiotics in ... cause for concern. The use of antibiotics ... human consumption contribute to the development of antibiotic-resistant ... information from the study. Each year in ... million people and kill about 23,000, according to ...
(Date:10/25/2014)... (HealthDay News) -- Current osteoporosis screening guidelines and ... at risk for osteoporosis-related fractures, a new study ... we need tools that help us accurately predict ... we can target these at-risk people for preventive ... medicine in the division of general internal medicine ...
(Date:10/25/2014)... 24, 2014 (HealthDay News) -- October,s shorter, darker days ... affective disorder, according to an expert. People ... feel overly tired, lack motivation and even have trouble ... lead to suicide, said Dr. Angelos Halaris, a professor ... Loyola University Chicago Stitch School of Medicine. "Seasonal ...
(Date:10/22/2014)... 22, 2014 On Saturday, October 25, 2014, ... annual family health and fitness fair ¡Vive tu vida! Get ... and good nutrition for better health and wellness for people ... free and open to the public, will be held at ... 9:00 am to 1:00 pm. , “¡Vive tu Vida! ...
Breaking Medicine News(10 mins):Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:Osteoporosis Screening Guidelines May Miss Younger Women at Risk 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
(Date:10/25/2014)... -- Burzynski Research Institute, Inc. (BRI) announced today that ... the company permission to conduct an open-label study of ... of age with a diffuse intrinsic brainstem glioma (DIPG). ... treatment groups based on their age and whether or ... primary study endpoint is a decrease in the size ...
(Date:10/22/2014)... 2014  Cephasonics, a technology-innovation leader with a game-changing ... (cQuest Ultrasound Box™-1), the first product in a new ... by Cephasonics for purchase by companies to rebrand with ... be showcasing the cQUB-1 for the first time at ... Chongqing, China from October 23 to ...
(Date:10/22/2014)... IRVINE, Calif. , Oct 22, 2014 ... Irvine, California , announced the receipt ... Small Business Innovation Research award (SBIR) from the National Institute of ... will fund the development of a Pan-HIV Protein Microarray ... the HIV-1 and HIV-2 subtypes and aid in the ...
Breaking Medicine Technology:Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic Brainstem Glioma 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2
Cached News: